| Peter A Koretsky Md Pa | |
|
2955 Pineda Plaza Way Ste 115 Melbourne FL 32940-7306 | |
| (321) 254-7375 | |
| (321) 254-7145 |
| Full Name | Peter A Koretsky Md Pa |
|---|---|
| Speciality | Internal Medicine |
| Location | 2955 Pineda Plaza Way Ste 115, Melbourne, Florida |
| Authorized Official Name and Position | Peter A Koretsky (PRESIDENT) |
| Authorized Official Contact | 3212547375 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Peter A Koretsky Md Pa 2955 Pineda Plaza Way Ste 115 Melbourne FL 32940-7306 Ph: (321) 254-7375 | Peter A Koretsky Md Pa 2955 Pineda Plaza Way Ste 115 Melbourne FL 32940-7306 Ph: (321) 254-7375 |
| NPI Number | 1124117791 |
|---|---|
| Provider Enumeration Date | 10/12/2006 |
| Last Update Date | 03/28/2014 |
| Medicare PECOS PAC ID | 6406874601 |
|---|---|
| Medicare Enrollment ID | O20051107000293 |
News Archive
VIVUS, Inc. today announced that additional data on Qnexa(TM), an investigational drug candidate for obesity, was presented at the 27th annual scientific meeting of The Obesity Society (TOS) in Washington D.C. Wesley W. Day, PhD, vice president of clinical development at VIVUS, presented the additional data from the company's two year-long phase 3 obesity trials during the Pharmacotherapy Update portion of the pre-conference on October 24, 2009.
Stroke patients prescribed a common antidepressant show no improvement compared with those given a dummy drug, a study has found.
Northstar Healthcare Inc. today announced that it received an advance in the amount of Cdn.$1,016,150 from Canada Healthcare Acquisition Inc., a corporation indirectly controlled by Dr. Donald L. Kramer, M.D., a former CEO and former director of Northstar.
No country is fully prepared for the next epidemic or pandemic, according to the first edition of the Global Health Security Index.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124117791 | NPI | - | NPPES |
| 2734737 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | (* (Not Available)) | Primary |
| Provider Name | Jill L Polet |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1861550964 PECOS PAC ID: 7911925946 Enrollment ID: I20051108000378 |
News Archive
VIVUS, Inc. today announced that additional data on Qnexa(TM), an investigational drug candidate for obesity, was presented at the 27th annual scientific meeting of The Obesity Society (TOS) in Washington D.C. Wesley W. Day, PhD, vice president of clinical development at VIVUS, presented the additional data from the company's two year-long phase 3 obesity trials during the Pharmacotherapy Update portion of the pre-conference on October 24, 2009.
Stroke patients prescribed a common antidepressant show no improvement compared with those given a dummy drug, a study has found.
Northstar Healthcare Inc. today announced that it received an advance in the amount of Cdn.$1,016,150 from Canada Healthcare Acquisition Inc., a corporation indirectly controlled by Dr. Donald L. Kramer, M.D., a former CEO and former director of Northstar.
No country is fully prepared for the next epidemic or pandemic, according to the first edition of the Global Health Security Index.
› Verified 4 days ago
| Provider Name | Peter A Koretsky |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1467556456 PECOS PAC ID: 5597783704 Enrollment ID: I20051108000411 |
News Archive
VIVUS, Inc. today announced that additional data on Qnexa(TM), an investigational drug candidate for obesity, was presented at the 27th annual scientific meeting of The Obesity Society (TOS) in Washington D.C. Wesley W. Day, PhD, vice president of clinical development at VIVUS, presented the additional data from the company's two year-long phase 3 obesity trials during the Pharmacotherapy Update portion of the pre-conference on October 24, 2009.
Stroke patients prescribed a common antidepressant show no improvement compared with those given a dummy drug, a study has found.
Northstar Healthcare Inc. today announced that it received an advance in the amount of Cdn.$1,016,150 from Canada Healthcare Acquisition Inc., a corporation indirectly controlled by Dr. Donald L. Kramer, M.D., a former CEO and former director of Northstar.
No country is fully prepared for the next epidemic or pandemic, according to the first edition of the Global Health Security Index.
› Verified 4 days ago
| Provider Name | Paige M Ahammer |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1407073943 PECOS PAC ID: 3476627936 Enrollment ID: I20080731000418 |
News Archive
VIVUS, Inc. today announced that additional data on Qnexa(TM), an investigational drug candidate for obesity, was presented at the 27th annual scientific meeting of The Obesity Society (TOS) in Washington D.C. Wesley W. Day, PhD, vice president of clinical development at VIVUS, presented the additional data from the company's two year-long phase 3 obesity trials during the Pharmacotherapy Update portion of the pre-conference on October 24, 2009.
Stroke patients prescribed a common antidepressant show no improvement compared with those given a dummy drug, a study has found.
Northstar Healthcare Inc. today announced that it received an advance in the amount of Cdn.$1,016,150 from Canada Healthcare Acquisition Inc., a corporation indirectly controlled by Dr. Donald L. Kramer, M.D., a former CEO and former director of Northstar.
No country is fully prepared for the next epidemic or pandemic, according to the first edition of the Global Health Security Index.
› Verified 4 days ago
| Provider Name | Sarah L Bachand |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1275314445 PECOS PAC ID: 4981050770 Enrollment ID: I20231031001770 |
News Archive
VIVUS, Inc. today announced that additional data on Qnexa(TM), an investigational drug candidate for obesity, was presented at the 27th annual scientific meeting of The Obesity Society (TOS) in Washington D.C. Wesley W. Day, PhD, vice president of clinical development at VIVUS, presented the additional data from the company's two year-long phase 3 obesity trials during the Pharmacotherapy Update portion of the pre-conference on October 24, 2009.
Stroke patients prescribed a common antidepressant show no improvement compared with those given a dummy drug, a study has found.
Northstar Healthcare Inc. today announced that it received an advance in the amount of Cdn.$1,016,150 from Canada Healthcare Acquisition Inc., a corporation indirectly controlled by Dr. Donald L. Kramer, M.D., a former CEO and former director of Northstar.
No country is fully prepared for the next epidemic or pandemic, according to the first edition of the Global Health Security Index.
› Verified 4 days ago
News Archive
VIVUS, Inc. today announced that additional data on Qnexa(TM), an investigational drug candidate for obesity, was presented at the 27th annual scientific meeting of The Obesity Society (TOS) in Washington D.C. Wesley W. Day, PhD, vice president of clinical development at VIVUS, presented the additional data from the company's two year-long phase 3 obesity trials during the Pharmacotherapy Update portion of the pre-conference on October 24, 2009.
Stroke patients prescribed a common antidepressant show no improvement compared with those given a dummy drug, a study has found.
Northstar Healthcare Inc. today announced that it received an advance in the amount of Cdn.$1,016,150 from Canada Healthcare Acquisition Inc., a corporation indirectly controlled by Dr. Donald L. Kramer, M.D., a former CEO and former director of Northstar.
No country is fully prepared for the next epidemic or pandemic, according to the first edition of the Global Health Security Index.
› Verified 4 days ago
Donald H. Dehaven Md Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 8057 Spyglass Hill Rd, Unit 104, Melbourne, FL 32940 Phone: 321-622-8943 Fax: 321-622-8945 | |
Comprehensive Health Care Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1495 N. Harbor City Blvd., Suite F, Melbourne, FL 32935 Phone: 321-253-0646 Fax: 321-253-1004 | |
Crane Creek Medical Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2222 S Harbor City Blvd, Melbourne, FL 32901 Phone: 321-725-5050 Fax: 321-725-9100 | |
Comprehensive Health Care Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1509 N Harbor City Blvd, Melbourne, FL 32935 Phone: 321-253-0846 Fax: 321-253-1004 | |
Sarno Clinic Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2120 Sarno Rd, Melbourne, FL 32935 Phone: 321-952-9696 Fax: 321-952-7937 | |
First Locums Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 3248 Cortona Dr, Melbourne, FL 32940 Phone: 321-735-8301 Fax: 321-735-8301 | |
Family First Physicians Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 520 E New Haven Ave, Melbourne, FL 32901 Phone: 321-722-5846 |